Open AccessAdverse Events (AE) and Laboratory Changes in a Real-World Population of Hepatitis C Virus (HCV)-Infected Patients With Chronic Kidney Disease (CKD) Treated With Sofosbuvir (SOF)-Based Therapy
Author(s) -
Elke S. Backman,
Guillermo A. Ortiz,
Gregory L. Hundemer,
Nneka N. Ufere,
Raymond T. Chung,
Meghan E. Sise
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.744
Subject(s) - medicine , sofosbuvir , hepatitis c virus , kidney disease , adverse effect , virology , virus , disease , hepatitis c , population , rescue therapy , intensive care medicine , immunology , ribavirin , environmental health